Literature DB >> 7250754

Prognostic factors in granulosa-cell tumors.

E Björkholm, C Silfverswärd.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7250754     DOI: 10.1016/0090-8258(81)90040-8

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  23 in total

1.  [Diagnosis and differential diagnosis of granulosa cell tumor].

Authors:  D Schmidt; F Kommoss
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

2.  Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

Authors:  Stine E Weis-Banke; Mads Lerdrup; Daniela Kleine-Kohlbrecher; Faizaan Mohammad; Simone Sidoli; Ole N Jensen; Toshihiko Yanase; Tomoko Nakamura; Akira Iwase; Anthe Stylianou; Nadeem R Abu-Rustum; Carol Aghajanian; Robert Soslow; Arnaud Da Cruz Paula; Richard P Koche; Britta Weigelt; Jesper Christensen; Kristian Helin; Paul A C Cloos
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

3.  Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Authors:  Melissa M Thrall; Pamela Paley; Ellen Pizer; Rochelle Garcia; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-04-09       Impact factor: 5.482

4.  Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.

Authors:  Sharif Sakr; Eman Abdulfatah; Sumi Thomas; Zaid Al-Wahab; Rafic Beydoun; Robert Morris; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay
Journal:  Int J Gynecol Pathol       Date:  2017-05       Impact factor: 2.762

5.  Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.

Authors:  Brooke S Middlebrook; Karen Eldin; Xiaohui Li; Sujatha Shivasankaran; Stephanie A Pangas
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

6.  Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.

Authors:  Jubilee Brown; William E Brady; Julian Schink; Linda Van Le; Mario Leitao; S Diane Yamada; Koen de Geest; David M Gershenson
Journal:  Cancer       Date:  2013-10-24       Impact factor: 6.860

7.  Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.

Authors:  Xia Tao; Anil K Sood; Michael T Deavers; Kathleen M Schmeler; Alpa M Nick; Robert L Coleman; Ljiljana Milojevic; David M Gershenson; Jubilee Brown
Journal:  Gynecol Oncol       Date:  2009-06-13       Impact factor: 5.482

8.  Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study.

Authors:  In Ho Lee; Chel Hun Choi; Dae Gy Hong; Jae Yun Song; Young Jae Kim; Kyung Tai Kim; Kyu Wan Lee; Il Soo Park; Duk Soo Bae; Tae Jin Kim
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

9.  Ovarian granulosa cell tumors: a retrospective study of 27 cases and a review of the literature.

Authors:  Sakina Sekkate; Mouna Kairouani; Badr Serji; Adnane Tazi; Hind Mrabti; Saber Boutayeb; Hassan Errihani
Journal:  World J Surg Oncol       Date:  2013-06-18       Impact factor: 2.754

10.  Fine map of the Gct1 spontaneous ovarian granulosa cell tumor locus.

Authors:  Kerri N Smith; Sarah J Halfyard; Edward S Yaskowiak; Kathryn L Shultz; Wesley G Beamer; Ann M Dorward
Journal:  Mamm Genome       Date:  2012-11-18       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.